Biolex Therapeutics, Inc.
Records under this name other than patents Biolex Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Biolex Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,394,384 | Recombinant Avian Influenza Vaccine and Uses Thereof now held by Merial, Inc. In force · High confidence | In force | High confidence | |
| US 9,345,759 | Bluetongue Virus Recombinant Vaccines and Uses Thereof now held by Merial, Inc. In force · High confidence | In force | High confidence | |
| US 7,468,151 | Method for the Preparation of Purified Microparticles Term ended Term ended Oct 22, 2024 · High confidence | Term ended | Term ended Oct 22, 2024 | High confidence |
| US 8,716,557 | Compositions and Methods for Inhibition of Fucosyltransferase and Xylosyltransferase Expression in Plants now held by Synthon Biopharmaceuticals B.V. Lapsed on the fee record Ended May 6, 2018 · High confidence | Lapsed on the fee record | Ended May 6, 2018 | High confidence |
| US 7,659,445 | Expression of Plasminogen and Microplasminogen in Duck Weed now held by Synthon Biopharmaceuticals B.V. Lapsed on the fee record Ended Feb 9, 2018 · High confidence | Lapsed on the fee record | Ended Feb 9, 2018 | High confidence |
| US 7,632,983 | Expression of Monoclonal Antibodies in Duckweed now held by Synthon Biopharmaceuticals B.V. Lapsed on the fee record Ended Dec 15, 2017 · High confidence | Lapsed on the fee record | Ended Dec 15, 2017 | High confidence |
| US 7,622,573 | Expression Control Elements from the Lemnaceae Family now held by Synthon Biopharmaceuticals B.V. Lapsed on the fee record Ended Nov 24, 2017 · High confidence | Lapsed on the fee record | Ended Nov 24, 2017 | High confidence |
| US 6,815,184 | Expression of Biologically Active Polypeptides in Duckweed now held by Synthon Biopharmaceuticals B.V. Lapsed on the fee record Ended Nov 9, 2016 · High confidence | Lapsed on the fee record | Ended Nov 9, 2016 | High confidence |
| US 8,137,661 | Controlled Release Interferon Drug Products and Treatment of HCV Infections Using Same Lapsed on the fee record Ended Mar 20, 2016 · High confidence | Lapsed on the fee record | Ended Mar 20, 2016 | High confidence |
| US 7,326,385 | Plate and Method for High Throughput Screening now held by Synthon Biopharmaceuticals B.V. Lapsed on the fee record Ended Feb 5, 2016 · High confidence | Lapsed on the fee record | Ended Feb 5, 2016 | High confidence |